News Conference News TCT 2012 Presentations Examine Multiple Facets of Antiplatelet Agents October 24, 2012
News Conference News ESC 2012 Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients Caitlin E. Cox August 27, 2012
News Conference News ACC 2012 ASCERT: Long-term Survival Advantage with CABG in Multivessel Disease Yael L. Maxwell March 27, 2012
News Conference News ACC 2012 New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding L.A. McKeown March 24, 2012
News Conference News PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease April 05, 2011